|
US5171680A
(en)
|
1988-06-14 |
1992-12-15 |
Chiron Corporation |
Superoxide dismutase analogs having novel binding properties
|
|
EP0416037B1
(en)
|
1988-06-14 |
1995-07-26 |
Chiron Corporation |
Superoxide dismutase analogs having novel binding properties
|
|
FR2640638B1
(fr)
|
1988-12-20 |
1991-02-15 |
Commissariat Energie Atomique |
Bioreacteur et dispositif pour la culture de cellules animales
|
|
AU7906691A
(en)
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
|
JPH08503855A
(ja)
|
1992-12-03 |
1996-04-30 |
ジェンザイム・コーポレイション |
嚢胞性線維症に対する遺伝子治療
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
KR100356615B1
(ko)
|
1993-07-13 |
2003-04-03 |
아방티 파르마 소시에테 아노님 |
결함아데노바이러스벡터및유전자치료에서그의사용
|
|
US5693531A
(en)
|
1993-11-24 |
1997-12-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vector systems for the generation of adeno-associated virus particles
|
|
WO1995028493A1
(en)
|
1994-04-13 |
1995-10-26 |
The Rockefeller University |
Aav-mediated delivery of dna to cells of the nervous system
|
|
US5658785A
(en)
|
1994-06-06 |
1997-08-19 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
|
US20020159979A1
(en)
|
1994-06-06 |
2002-10-31 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
|
US5856152A
(en)
|
1994-10-28 |
1999-01-05 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV vector and methods of use therefor
|
|
US5625048A
(en)
|
1994-11-10 |
1997-04-29 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
US5652224A
(en)
|
1995-02-24 |
1997-07-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
|
|
US5741657A
(en)
|
1995-03-20 |
1998-04-21 |
The Regents Of The University Of California |
Fluorogenic substrates for β-lactamase and methods of use
|
|
US6281010B1
(en)
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
|
US5756283A
(en)
|
1995-06-05 |
1998-05-26 |
The Trustees Of The University Of Pennsylvania |
Method for improved production of recombinant adeno-associated viruses for gene therapy
|
|
US5688676A
(en)
|
1995-06-07 |
1997-11-18 |
Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
US6197293B1
(en)
|
1997-03-03 |
2001-03-06 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
|
|
US6676935B2
(en)
|
1995-06-27 |
2004-01-13 |
Cell Genesys, Inc. |
Tissue specific adenoviral vectors
|
|
AU722196B2
(en)
|
1995-08-30 |
2000-07-27 |
Genzyme Corporation |
Chromatographic purification of adenovirus and AAV
|
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
|
US5846528A
(en)
|
1996-01-18 |
1998-12-08 |
Avigen, Inc. |
Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
|
|
US5962313A
(en)
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
|
US5858351A
(en)
|
1996-01-18 |
1999-01-12 |
Avigen, Inc. |
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
|
|
US5952221A
(en)
|
1996-03-06 |
1999-09-14 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a first and second nucleic acid sequence
|
|
JP4468488B2
(ja)
|
1996-05-29 |
2010-05-26 |
コーネル・リサーチ・ファンデーション・インコーポレイテッド |
組み合せたリガーゼ検出およびポリメラーゼ連鎖反応を用いる核酸配列相違の検出
|
|
US7026468B2
(en)
|
1996-07-19 |
2006-04-11 |
Valentis, Inc. |
Process and equipment for plasmid purification
|
|
EP0950111A1
(en)
|
1996-09-06 |
1999-10-20 |
The Trustees Of The University Of Pennsylvania |
Methods using cre-lox for production of recombinant adeno-associated viruses
|
|
AU4255397A
(en)
|
1996-09-06 |
1998-03-26 |
Trustees Of The University Of Pennsylvania, The |
Chimpanzee adenovirus vectors
|
|
US20020037867A1
(en)
|
1999-02-26 |
2002-03-28 |
James M. Wilson |
Method for recombinant adeno-associated virus-directed gene therapy
|
|
US5866552A
(en)
|
1996-09-06 |
1999-02-02 |
The Trustees Of The University Of Pennsylvania |
Method for expressing a gene in the absence of an immune response
|
|
CN1233291A
(zh)
|
1996-09-06 |
1999-10-27 |
宾西法尼亚大学托管会 |
重组腺伴随病毒定向基因治疗的方法
|
|
EP0931158A1
(en)
|
1996-09-06 |
1999-07-28 |
The Trustees Of The University Of Pennsylvania |
An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
|
|
EP0932694A2
(en)
|
1996-09-11 |
1999-08-04 |
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Aav4 vector and uses thereof
|
|
JP4492826B2
(ja)
|
1996-11-20 |
2010-06-30 |
イントロジェン セラピューティクス，インコーポレイテッド |
アデノウイルスベクターの産生および精製のための改良された方法
|
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
WO1998027204A2
(en)
|
1996-12-18 |
1998-06-25 |
Targeted Genetics Corporation |
Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US6710036B2
(en)
|
1997-07-25 |
2004-03-23 |
Avigen, Inc. |
Induction of immune response to antigens expressed by recombinant adeno-associated virus
|
|
US6251677B1
(en)
|
1997-08-25 |
2001-06-26 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
|
US6989264B2
(en)
|
1997-09-05 |
2006-01-24 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
US6566118B1
(en)
|
1997-09-05 |
2003-05-20 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
WO1999015677A1
(en)
|
1997-09-19 |
1999-04-01 |
The Trustees Of The University Of Pennsylvania |
Method for gene transfer using bcl2 and compositions useful therein
|
|
EP1015619A1
(en)
|
1997-09-19 |
2000-07-05 |
The Trustees Of The University Of Pennsylvania |
Methods and cell line useful for production of recombinant adeno-associated viruses
|
|
CA2303768C
(en)
|
1997-09-19 |
2009-11-24 |
The Trustees Of The University Of Pennsylvania |
Methods and vector constructs useful for production of recombinant aav
|
|
US6642051B1
(en)
|
1997-10-21 |
2003-11-04 |
Targeted Genetics Corporation |
Amplifiable adeno-associated virus(AAV) packaging cassettes for the production of recombinant AAV vectors
|
|
IT1297074B1
(it)
|
1997-11-21 |
1999-08-03 |
Angeletti P Ist Richerche Bio |
Forme ormone-dipendenti delle proteine rep del virus adeno-associato (aav-2), sequenze di dna codificanti per esse, vettori che le
|
|
JP2001526900A
(ja)
|
1997-12-23 |
2001-12-25 |
イントロヘーネ ベスローテン フェンノートシャップ |
標的細胞の染色体ｄｎａへの外来遺伝子情報の組み込みに有用な、アデノ随伴ウイルスおよびアデノウイルスのキメラ組換えウイルス
|
|
US6410300B1
(en)
|
1998-01-12 |
2002-06-25 |
The University Of North Carolina At Chapel Hill |
Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
|
|
AU2882899A
(en)
|
1998-02-26 |
1999-09-15 |
Trustees Of The University Of Pennsylvania, The |
Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex
|
|
US6953690B1
(en)
|
1998-03-20 |
2005-10-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
US6521426B1
(en)
|
1998-04-08 |
2003-02-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Preparation of recombinant adenovirus carrying a rep gene of adeno-associated virus
|
|
FR2778413B1
(fr)
|
1998-05-07 |
2000-08-04 |
Immunotech Sa |
Nouveaux reactifs et methode de lyse des erythrocytes
|
|
WO1999058700A1
(en)
|
1998-05-11 |
1999-11-18 |
Ariad Gene Therapeutics, Inc. |
Multiviral compositions and uses thereof
|
|
EP1849872A1
(en)
|
1998-05-20 |
2007-10-31 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors and uses thereof
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
EP1082445A2
(en)
|
1998-05-27 |
2001-03-14 |
Cell Genesys, Inc. |
Adeno-associated viral vector-mediated expression of factor viii activity
|
|
EP1080218A1
(en)
|
1998-05-27 |
2001-03-07 |
University of Florida |
Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
DE69939169D1
(de)
|
1998-05-28 |
2008-09-04 |
Us Gov Health & Human Serv |
Aav5 vektoren und deren verwendung
|
|
GB2338236B
(en)
|
1998-06-13 |
2003-04-09 |
Aea Technology Plc |
Microbiological cell processing
|
|
US6900049B2
(en)
|
1998-09-10 |
2005-05-31 |
Cell Genesys, Inc. |
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
|
|
WO2000022152A1
(en)
|
1998-10-13 |
2000-04-20 |
Avigen, Inc. |
Compositions and methods for producing recombinant adeno-associated virus
|
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
JP2002528087A
(ja)
|
1998-10-27 |
2002-09-03 |
クルセル ホランド ベー ヴェー |
改良ａａｖベクター産生
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
ATE454445T1
(de)
|
1998-11-10 |
2010-01-15 |
Univ North Carolina |
Virusvektoren und verfahren für ihre herstellung und verabreichung.
|
|
US6689600B1
(en)
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
US6759050B1
(en)
|
1998-12-03 |
2004-07-06 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
US6225113B1
(en)
|
1998-12-04 |
2001-05-01 |
Genvec, Inc. |
Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus
|
|
US6387368B1
(en)
|
1999-02-08 |
2002-05-14 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
|
DE19905501B4
(de)
|
1999-02-10 |
2005-05-19 |
MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie |
Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels
|
|
US6509150B1
(en)
|
1999-03-05 |
2003-01-21 |
Universite De Nantes |
Compositions and methods for recombinant Adeno-Associated Virus production
|
|
US6258595B1
(en)
|
1999-03-18 |
2001-07-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
JP4693244B2
(ja)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
|
|
CA2368194A1
(en)
|
1999-04-30 |
2000-11-09 |
University Of Florida |
Adeno-associated virus-delivered ribozyme compositions and methods of use
|
|
AU2409200A
(en)
|
1999-06-02 |
2000-12-28 |
Trustees Of The University Of Pennsylvania, The |
Compositions and methods useful for production of recombinant viruses which require helper viruses
|
|
CA2376400A1
(en)
|
1999-06-08 |
2000-12-14 |
University Of Iowa Research Foundation |
Compounds and methods to enhance raav transduction
|
|
AU781478B2
(en)
|
1999-08-20 |
2005-05-26 |
Johns Hopkins University School Of Medicine, The |
Methods and compositions for the construction and use of fusion libraries
|
|
EP1218035A2
(en)
|
1999-09-29 |
2002-07-03 |
The Trustees Of The University Of Pennsylvania |
Rapid peg-modification of viral vectors
|
|
US6365394B1
(en)
|
1999-09-29 |
2002-04-02 |
The Trustees Of The University Of Pennsylvania |
Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
|
|
CA2386546A1
(en)
|
1999-10-07 |
2001-04-12 |
University Of Iowa Research Foundation |
Adeno-associated viruses and uses thereof
|
|
US7241447B1
(en)
|
1999-10-07 |
2007-07-10 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors and uses thereof
|
|
WO2001032711A2
(en)
|
1999-10-21 |
2001-05-10 |
Board Of Trustees Of The University Of Arkansas |
Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof
|
|
WO2001036623A2
(en)
|
1999-11-05 |
2001-05-25 |
Avigen, Inc. |
Ecdysone-inducible adeno-associated virus expression vectors
|
|
US6582692B1
(en)
|
1999-11-17 |
2003-06-24 |
Avigen, Inc. |
Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
|
|
AU1954001A
(en)
|
1999-12-10 |
2001-06-18 |
Ariad Gene Therapeutics, Inc. |
Methods for high level expression of genes in primates
|
|
US7638120B2
(en)
|
2000-03-14 |
2009-12-29 |
Thomas Jefferson University |
High transgene expression of a pseudotyped adeno-associated virus type
|
|
US20020045264A1
(en)
|
2000-03-14 |
2002-04-18 |
During Matthew J. |
Production of chimeric capsid vectors
|
|
US6855314B1
(en)
|
2000-03-22 |
2005-02-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector for transducing brain cells and lung cells
|
|
US6468524B1
(en)
|
2000-03-22 |
2002-10-22 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
AAV4 vector and uses thereof
|
|
US7048920B2
(en)
|
2000-03-24 |
2006-05-23 |
Cell Genesys, Inc. |
Recombinant oncolytic adenovirus for human melanoma
|
|
PT1309726E
(pt)
|
2000-03-30 |
2010-03-08 |
Whitehead Biomedical Inst |
Mediadores de interferência por rna específicos de sequência de rna
|
|
GB0009887D0
(en)
|
2000-04-20 |
2000-06-07 |
Btg Int Ltd |
Cytotoxic agents
|
|
JP2004514407A
(ja)
|
2000-04-28 |
2004-05-20 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
異種キャプシド中にシュードタイピングされたａａｖ５キャプシドおよびａａｖ５ベクターを含む組換えａａｖベクター
|
|
US20030013189A1
(en)
|
2000-04-28 |
2003-01-16 |
Wilson James M. |
Compositions and methods useful for non-invasive delivery of therapeutic molecules to the bloodstream
|
|
US7125705B2
(en)
|
2000-04-28 |
2006-10-24 |
Genzyme Corporation |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
NZ522840A
(en)
|
2000-06-01 |
2004-12-24 |
Univ North Carolina |
A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together
|
|
AU2001268373A1
(en)
|
2000-06-13 |
2001-12-24 |
The Children's Hospital Of Philadelphia |
Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
|
|
ATE364698T1
(de)
|
2000-07-18 |
2007-07-15 |
Takeda Pharmaceutical |
Neues, physiologisch aktives peptid und dessen verwendung
|
|
US6593123B1
(en)
|
2000-08-07 |
2003-07-15 |
Avigen, Inc. |
Large-scale recombinant adeno-associated virus (rAAV) production and purification
|
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
|
DE60129229T2
(de)
|
2000-08-17 |
2008-05-08 |
Ozawa, Keiya |
Adeno-assoziierte virus-vermittelte übertragung von angiogenesefaktoren
|
|
DE10066104A1
(de)
|
2000-09-08 |
2003-01-09 |
Medigene Ag |
Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung
|
|
FR2813891B1
(fr)
|
2000-09-14 |
2005-01-14 |
Immunotech Sa |
Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
|
|
ES2248144T3
(es)
|
2000-10-24 |
2006-03-16 |
Mitsubishi Pharma Corporation |
Medicamentos para tratar la esclerosis lateral amiotrofica (ela).
|
|
JP2002153278A
(ja)
|
2000-11-22 |
2002-05-28 |
Hisamitsu Pharmaceut Co Inc |
ウイルスベクターの製造に用いられる細胞、その製法およびその細胞を用いたウイルスベクターの製造方法
|
|
WO2002070719A2
(en)
|
2001-01-19 |
2002-09-12 |
Trustees Of The University Of Pennsylvania |
Regulatable gene expression system
|
|
CA2441454A1
(en)
|
2001-03-14 |
2002-09-19 |
Avigen, Inc. |
Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions
|
|
CA2451643C
(en)
|
2001-06-21 |
2012-11-13 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of superoxide dismutase 1, soluble expression
|
|
US20040136963A1
(en)
|
2001-06-22 |
2004-07-15 |
The Trustees Of The University Of Pennsylvania |
Simian adenovirus vectors and methods of use
|
|
ATE530672T1
(de)
|
2001-06-22 |
2011-11-15 |
Univ Pennsylvania |
Rekombinante adenoviren mit affen-adenovirus proteinen und verwendung davon.
|
|
AU2007201330C1
(en)
|
2001-07-12 |
2011-06-09 |
University Of Massachusetts |
In vivo production of small interfering RNAs that mediate gene silencing
|
|
IL159756A0
(en)
|
2001-07-12 |
2004-06-20 |
Univ Massachusetts |
IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING
|
|
EP1900815B1
(en)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In vivo production of small interfering RNAs that mediate gene silencing
|
|
US8241622B2
(en)
|
2001-07-13 |
2012-08-14 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
|
|
US20030016777A1
(en)
|
2001-07-18 |
2003-01-23 |
Alain Vandergheynst |
TIG welded MOX fuel rod
|
|
EP1279740A1
(en)
|
2001-07-26 |
2003-01-29 |
Vrije Universiteit Brussel |
Recombinant vector derived from adeno-associated virus for gene therapy
|
|
CA2455499C
(en)
|
2001-08-08 |
2011-06-21 |
The Trustees Of The University Of Pennsylvania |
Method for purification of viral vectors having proteins which bind sialic acid
|
|
US20030092161A1
(en)
|
2001-09-19 |
2003-05-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for production of recombinant viruses, and uses therefor
|
|
JP4371812B2
(ja)
|
2001-09-28 |
2009-11-25 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
マイクロｒｎａ分子
|
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
WO2003042361A2
(en)
|
2001-11-09 |
2003-05-22 |
Government Of The United States Of America, Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
CN103555677B
(zh)
|
2001-11-13 |
2018-01-30 |
宾夕法尼亚大学托管会 |
检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
|
|
HU230364B1
(hu)
|
2001-11-21 |
2016-03-29 |
The Trustees Of The University Of Pennsylvania |
Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására
|
|
EP1944043A1
(en)
|
2001-11-21 |
2008-07-16 |
The Trustees of the University of Pennsylvania |
Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
|
|
JP4550421B2
(ja)
|
2001-12-12 |
2010-09-22 |
メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド |
ウイルスの保存のための組成物
|
|
PT2573170T
(pt)
|
2001-12-17 |
2018-03-26 |
Univ Pennsylvania |
Sequências de um vírus adenoassociado (aav) de serotipo 9, vetor contendo as mesmas, e suas utilizações
|
|
WO2003052051A2
(en)
|
2001-12-17 |
2003-06-26 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (aav) serotype 8 sequences
|
|
CA2469658A1
(en)
|
2001-12-19 |
2003-07-03 |
Lijun Wang |
Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
|
|
AU2003202026A1
(en)
|
2002-01-16 |
2003-09-02 |
Dynal Biotech Asa |
Method for isolating nucleic acids and protein from a single sample
|
|
US20030180756A1
(en)
|
2002-03-21 |
2003-09-25 |
Yang Shi |
Compositions and methods for suppressing eukaryotic gene expression
|
|
GB0208390D0
(en)
|
2002-04-11 |
2002-05-22 |
Univ London |
Adeno-associated virus producer system
|
|
US20030198620A1
(en)
|
2002-04-16 |
2003-10-23 |
Keiya Ozawa |
Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
|
|
CA2426283C
(en)
|
2002-04-29 |
2006-06-27 |
The Trustees Of The University Of Pennsylvania |
Method for direct rescue and amplification of integrated viruses from cellular dna of tissues
|
|
DK1501921T4
(da)
|
2002-04-30 |
2012-10-08 |
Oncolytics Biotech Inc |
Forbedrede virusrensningsmetoder
|
|
EP1496944B1
(en)
|
2002-05-01 |
2008-08-20 |
University of Florida Research Foundation, Inc. |
Improved raav expression systems for genetic modification of specific capsid proteins
|
|
WO2003093441A2
(en)
|
2002-05-03 |
2003-11-13 |
Duke University |
A method of regulating gene expression
|
|
ES2285120T3
(es)
|
2002-05-14 |
2007-11-16 |
MERCK & CO., INC. |
Procedimientos de purificacion de adenovirus.
|
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
|
AU2003274397A1
(en)
|
2002-06-05 |
2003-12-22 |
University Of Florida |
Production of pseudotyped recombinant aav virions
|
|
US20080274989A1
(en)
|
2002-08-05 |
2008-11-06 |
University Of Iowa Research Foundation |
Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
|
|
US20040241854A1
(en)
|
2002-08-05 |
2004-12-02 |
Davidson Beverly L. |
siRNA-mediated gene silencing
|
|
US20050255086A1
(en)
|
2002-08-05 |
2005-11-17 |
Davidson Beverly L |
Nucleic acid silencing of Huntington's Disease gene
|
|
WO2004020605A2
(en)
|
2002-08-29 |
2004-03-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circular nucleic acid vectors, and methods for making and using the same
|
|
AU2003273336A1
(en)
|
2002-09-18 |
2004-04-08 |
Isis Pharmaceuticals, Inc. |
Efficient reduction of target rna's by single- and double-stranded oligomeric compounds
|
|
US7892793B2
(en)
|
2002-11-04 |
2011-02-22 |
University Of Massachusetts |
Allele-specific RNA interference
|
|
US20060041022A1
(en)
|
2002-11-06 |
2006-02-23 |
Pasinetti Giulio M |
Treatment of amyotrophic lateral sclerosis with nimesulide
|
|
US7169612B2
(en)
|
2002-11-11 |
2007-01-30 |
Sanofi-Aventis Deutschland Gmbh |
Use of EDG2 receptor in an animal model of heart failure
|
|
EP1418185A1
(en)
|
2002-11-11 |
2004-05-12 |
Aventis Pharma Deutschland GmbH |
Use of EDG2 receptor in an animal model of heart failure
|
|
WO2006006948A2
(en)
|
2002-11-14 |
2006-01-19 |
Dharmacon, Inc. |
METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
|
|
US8090542B2
(en)
|
2002-11-14 |
2012-01-03 |
Dharmacon Inc. |
Functional and hyperfunctional siRNA
|
|
US7618948B2
(en)
|
2002-11-26 |
2009-11-17 |
Medtronic, Inc. |
Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
|
|
EP1611231A4
(en)
|
2003-02-21 |
2008-08-13 |
Penn State Res Found |
RNA-INTERFERING COMPOSITIONS AND METHODS THEREOF
|
|
US7510872B2
(en)
|
2003-02-26 |
2009-03-31 |
Nationwide Children's Hospital |
Recombinant adeno-associated virus production
|
|
WO2004083441A2
(en)
|
2003-03-19 |
2004-09-30 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Random peptide library displayed on aav vectors
|
|
WO2004108922A2
(en)
|
2003-04-25 |
2004-12-16 |
The Trustees Of The University Of Pennsylvania |
Use of aav comprising a capsid protein from aav7 or aav8 for the delivery of genes encoding apoprotein a or e genes to the liver
|
|
WO2005017101A2
(en)
|
2003-05-19 |
2005-02-24 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH |
Avian adenoassociated virus (aaav) and uses thereof
|
|
ES2521682T3
(es)
|
2003-05-21 |
2014-11-13 |
Genzyme Corporation |
Procedimientos para producir preparaciones de viriones de AAV recombinantes sustancialmente exentas de cápsidas vacías
|
|
US7750144B2
(en)
|
2003-06-02 |
2010-07-06 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of RNA silencing
|
|
ATE485394T1
(de)
|
2003-06-02 |
2010-11-15 |
Univ Massachusetts |
Verfahren und zusammensetzungen zur verbesserung der wirksamkeit und spezifität von fnai
|
|
US7459547B2
(en)
|
2003-06-02 |
2008-12-02 |
University Of Massachusetts |
Methods and compositions for controlling efficacy of RNA silencing
|
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
JP4888876B2
(ja)
|
2003-06-13 |
2012-02-29 |
田平 武 |
アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター
|
|
JP2007524386A
(ja)
|
2003-06-19 |
2007-08-30 |
アビジェン， インコーポレイテッド |
減少した免疫反応性を有するａａｖビリオン、およびその使用
|
|
US7291498B2
(en)
|
2003-06-20 |
2007-11-06 |
The Trustees Of The University Of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
|
JP4754480B2
(ja)
|
2003-06-20 |
2011-08-24 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
キメラアデノウイルスの作成法およびそのようなキメラアデノウイルスの使用
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
WO2005007875A2
(en)
|
2003-07-18 |
2005-01-27 |
University Of Massachusetts |
Enhanced promoters for synthesis of small hairpin rna
|
|
WO2005012537A2
(en)
|
2003-07-25 |
2005-02-10 |
Genvec, Inc. |
Adenoviral vector-based vaccines
|
|
WO2005013901A2
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
|
US20070003977A1
(en)
|
2003-08-20 |
2007-01-04 |
Amorfix Life Sciences Ltd |
Epitope protection assay and method for detecting protein conformations
|
|
ES2485848T3
(es)
|
2003-09-12 |
2014-08-14 |
University Of Massachusetts |
ARN de interferencia para el tratamiento de trastornos relacionados con la ganancia de función
|
|
US20050064489A1
(en)
|
2003-09-24 |
2005-03-24 |
Zhang Fang Liang |
Engineered U6 and H1 promoters
|
|
DK3211085T3
(da)
|
2003-09-30 |
2021-06-21 |
Univ Pennsylvania |
Klader af adeno-associeret virus (aav), sekvenser, vektorer indeholdende disse og anvendelser deraf
|
|
ES2687645T3
(es)
|
2003-10-27 |
2018-10-26 |
Merck Sharp & Dohme Corp. |
Método de diseño de ARNip para el silenciamiento de genes
|
|
WO2005062937A2
(en)
|
2003-12-22 |
2005-07-14 |
University Of Massachusetts |
Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended sirna
|
|
US20050182425A1
(en)
|
2004-02-13 |
2005-08-18 |
Schulte Gregory T. |
Methods and apparatus for securing a therapy delivery device within a burr hole
|
|
WO2005087926A2
(en)
|
2004-03-05 |
2005-09-22 |
Benitec, Inc. |
Multiple promoter expression cassettes for simultaneous delivery of rnai agents
|
|
WO2005096781A2
(en)
|
2004-04-06 |
2005-10-20 |
University Of Massachusetts |
Methods and compositions for treating gain-of-function disorders using rna interference
|
|
ES2361000T3
(es)
|
2004-04-28 |
2011-06-13 |
The Trustees Of The University Of Pennsylvania |
Suministro secuencial de moléculas inmunogénicas mediante administraciones de un adenovirus y de un virus adeno-asociado.
|
|
GB0412072D0
(en)
*
|
2004-05-28 |
2004-06-30 |
Syngenta Participations Ag |
Chemical compounds
|
|
MXPA06014030A
(es)
|
2004-06-01 |
2007-10-08 |
Genzyme Corp |
Composiciones y metodos para evitar la agregacion del vector aav.
|
|
EP2572661B1
(en)
|
2004-10-05 |
2019-11-20 |
Genzyme Corporation |
Stepped cannula
|
|
US7901921B2
(en)
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
JP2008520243A
(ja)
|
2004-11-18 |
2008-06-19 |
ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ |
腫瘍を阻害するための多シストロン性ｓｉＲＮＡコンストラクト
|
|
CN1286981C
(zh)
|
2004-11-30 |
2006-11-29 |
华中科技大学同济医学院附属同济医院 |
表达人类cyp2j2反义基因的重组腺相关病毒及其制备方法
|
|
US7892809B2
(en)
|
2004-12-15 |
2011-02-22 |
The University Of North Carolina At Chapel Hill |
Chimeric vectors
|
|
WO2006066203A2
(en)
*
|
2004-12-16 |
2006-06-22 |
Alsgen, Llc |
Small interfering rna (sirna) molecules for modulating superoxide dismutase (sod)
|
|
JP4292416B2
(ja)
|
2005-01-12 |
2009-07-08 |
住友電気工業株式会社 |
超電導ケーブルの端末構造
|
|
WO2006084209A2
(en)
|
2005-02-03 |
2006-08-10 |
Benitec, Inc. |
Rnai expression constructs
|
|
US8614101B2
(en)
|
2008-05-20 |
2013-12-24 |
Rapid Pathogen Screening, Inc. |
In situ lysis of cells in lateral flow immunoassays
|
|
US7625570B1
(en)
|
2005-03-10 |
2009-12-01 |
The Regents Of The University Of California |
Methods for purifying adeno-associated virus
|
|
WO2006102072A2
(en)
|
2005-03-23 |
2006-09-28 |
The Trustees Of The University Of Pennsylvania |
Use of a pa131 polypeptide in treatment of atherosclerosis
|
|
US8999678B2
(en)
|
2005-04-07 |
2015-04-07 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an AAV vector
|
|
WO2006119432A2
(en)
|
2005-04-29 |
2006-11-09 |
The Government Of The U.S.A., As Rep. By The Sec., Dept. Of Health & Human Services |
Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
|
|
PT2420256T
(pt)
|
2005-05-02 |
2016-09-13 |
Genzyme Corp |
Terapia genética para distúrbios neurometabólicos
|
|
WO2007022470A2
(en)
|
2005-08-18 |
2007-02-22 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for treating neurological disease
|
|
AU2006283189B2
(en)
|
2005-08-23 |
2013-01-31 |
The Regents Of The University Of California |
Reflux resistant cannula and system for chronic delivery of therapeutic agents using convection-enhanced delivery
|
|
EP1857552A1
(en)
|
2006-05-20 |
2007-11-21 |
Cargill Incorporated |
Thermostable xylose isomerase enzyme
|
|
EP2311967B1
(en)
|
2005-10-20 |
2017-09-20 |
UniQure IP B.V. |
Improved AAV vectors produced in insect cells
|
|
US7794692B2
(en)
|
2005-12-02 |
2010-09-14 |
Amorfix Life Sciences Ltd. |
Methods and compositions for detecting amyotrophic lateral sclerosis
|
|
US7887803B2
(en)
|
2005-12-02 |
2011-02-15 |
Amorfix Life Sciences |
Methods and compositions to treat misfolded-SOD1 mediated diseases
|
|
AU2007210034A1
(en)
|
2006-01-26 |
2007-08-09 |
University Of Massachusetts |
RNA silencing agents for use in therapy and nanotransporters for efficient delivery of same
|
|
WO2007089632A2
(en)
|
2006-01-27 |
2007-08-09 |
The University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
WO2008016391A2
(en)
|
2006-01-31 |
2008-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
|
CA2642848C
(en)
|
2006-03-03 |
2016-07-12 |
Amorfix Life Sciences Ltd. |
Methods and compositions to treat and detect misfolded-sod1 mediated diseases
|
|
EP1993611A4
(en)
*
|
2006-03-16 |
2013-05-22 |
Alnylam Pharmaceuticals Inc |
RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES
|
|
US7588772B2
(en)
|
2006-03-30 |
2009-09-15 |
Board Of Trustees Of The Leland Stamford Junior University |
AAV capsid library and AAV capsid proteins
|
|
ES2715625T3
(es)
|
2006-04-03 |
2019-06-05 |
Roche Innovation Ct Copenhagen As |
Composición farmacéutica que comprende oligonucleótidos antisentido anti-miARN
|
|
EP2018421B1
(en)
|
2006-04-28 |
2012-12-19 |
The Trustees of the University of Pennsylvania |
Scalable production method for aav
|
|
DE602007004470D1
(de)
|
2006-04-28 |
2010-03-11 |
Univ Pennsylvania |
Modifiziertes adenovirus-hexon-protein und anwendungen davon
|
|
US20090317417A1
(en)
|
2006-04-28 |
2009-12-24 |
The Trustees Of The University Of Pennsylvania |
Modified AAV Vectors Having Reduced Capsid Immunogenicity and Use Thereof
|
|
US20080003565A1
(en)
|
2006-05-02 |
2008-01-03 |
Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services |
Viral nucleic acid microarray and method of use
|
|
CA3044969A1
(en)
|
2006-05-05 |
2007-12-21 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for modulating gene expression
|
|
EP2019839B1
(en)
|
2006-05-25 |
2011-12-07 |
Sangamo BioSciences, Inc. |
Methods and compositions for gene inactivation
|
|
KR101589259B1
(ko)
|
2006-06-21 |
2016-02-01 |
유니큐어 아이피 비.브이. |
곤충세포 내 ａａｖ의 생산에 유용한 ａａｖ-ｒｅｐ78의 번역을 위한 변형된 개시 코돈을 갖는 벡터
|
|
AU2007275010B2
(en)
|
2006-07-21 |
2013-06-20 |
California Institute Of Technology |
Targeted gene delivery for dendritic cell vaccination
|
|
ES2385679T3
(es)
|
2006-08-24 |
2012-07-30 |
Virovek, Inc. |
Expresión de células de insecto de genes con marcos de lectura abiertos superpuestos, métodos y composiciones de éstos
|
|
FR2905806B1
(fr)
|
2006-09-13 |
2008-12-26 |
Valeo Equip Electr Moteur |
Arbre de rotor a griffes, rotor a griffes equipe d'un tel arbre et machine electrique tournante equipee d'un tel rotor
|
|
DK2066791T3
(da)
|
2006-10-03 |
2012-10-15 |
Genzyme Corp |
Genterapi for amyotrofisk lateralsklerose og andre rygmarvssygdomme
|
|
US7794443B2
(en)
|
2006-10-24 |
2010-09-14 |
Medtronic, Inc. |
System and method for intraparenchymal drug infusion
|
|
ES2569365T3
(es)
|
2006-11-29 |
2016-05-10 |
Nationwide Children's Hospital |
Inhibición de miostatina para la potenciación de músculo y/o la mejora de la función muscular
|
|
US8227592B2
(en)
|
2006-11-29 |
2012-07-24 |
University Of Iowa Research Foundation |
Alternative export pathways for vector expressed RNA interference
|
|
US8183219B2
(en)
|
2007-01-03 |
2012-05-22 |
Medtronic, Inc. |
Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
|
|
US8173614B2
(en)
|
2007-01-03 |
2012-05-08 |
Medtronic, Inc. |
Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
|
|
WO2008094516A2
(en)
|
2007-01-29 |
2008-08-07 |
City Of Hope |
Multi-targeting short interfering rnas
|
|
UA99452C2
(ru)
|
2007-02-02 |
2012-08-27 |
Байоджэн Айдэк Ма Инк. |
Способ стимулирования миелинизации и дифференцирования олигодендроцитов путем применения семафорина 6a
|
|
EP2623605B1
(en)
|
2007-04-09 |
2018-11-28 |
University of Florida Research Foundation, Inc. |
RAAV vector compositions having tyrosine-modified capsid proteins and methods for use
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
US9611302B2
(en)
|
2007-04-09 |
2017-04-04 |
University Of Florida Research Foundation, Inc. |
High-transduction-efficiency RAAV vectors, compositions, and methods of use
|
|
WO2008128251A1
(en)
|
2007-04-17 |
2008-10-23 |
The Children's Hospital Of Philadelphia |
Humanized viral vectors and methods of use thereof
|
|
WO2008134646A2
(en)
|
2007-04-26 |
2008-11-06 |
University Of Iowa Research Foundation |
Rna interference suppression of neurodegenerative diseases and methods of use thereof
|
|
US20100203083A1
(en)
|
2007-05-31 |
2010-08-12 |
Medigene Ag |
Mutated structural protein of a parvovirus
|
|
EP2012122A1
(en)
|
2007-07-06 |
2009-01-07 |
Medigene AG |
Mutated parvovirus structural proteins as vaccines
|
|
PT2164967E
(pt)
|
2007-05-31 |
2015-10-27 |
Univ Iowa Res Found |
Redução da toxicidade não dirigida do arn de interferência
|
|
US8841437B2
(en)
|
2008-06-20 |
2014-09-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Precursor miRNA loop-modulated target regulation
|
|
AU2008271658B8
(en)
|
2007-06-29 |
2013-07-04 |
F. Hoffmann-La Roche Ag |
Promoter
|
|
US20110111496A1
(en)
|
2007-06-29 |
2011-05-12 |
Chiang Li |
BACTERIA-MEDIATED GENE MODULATION VIA microRNA MACHINERY
|
|
US8299215B2
(en)
|
2007-07-14 |
2012-10-30 |
University Of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
|
EP2019143A1
(en)
|
2007-07-23 |
2009-01-28 |
Genethon |
CNS gene delivery using peripheral administration of AAV vectors
|
|
DK3093345T3
(da)
|
2007-07-26 |
2019-06-24 |
Uniqure Ip Bv |
Baculovirusvektorer omfattende gentagne kodende sekvenser med differentielle foretrukne kodoner
|
|
DK2193140T3
(en)
|
2007-08-27 |
2017-01-23 |
Iglobe Health Inst Llc |
COMPOSITIONS OF ASYMMETRIC INTERFERRING RNA AND ITS APPLICATIONS
|
|
US8420372B2
(en)
|
2007-09-04 |
2013-04-16 |
Alexander Bello |
Porcine adeno-associated viruses
|
|
WO2009038462A1
(en)
|
2007-09-19 |
2009-03-26 |
Amsterdam Molecular Therapeutics B.V. |
Use of aav replication machinery for improved protein production
|
|
EP2058401A1
(en)
|
2007-10-05 |
2009-05-13 |
Genethon |
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
|
|
WO2009051421A2
(en)
|
2007-10-18 |
2009-04-23 |
Lg Electronics Inc. |
Method and system for transmitting and receiving signals
|
|
CN102131920B
(zh)
|
2007-11-28 |
2013-11-06 |
宾夕法尼亚大学托管会 |
猿猴亚家族C腺病毒SAdV-40、-31和-34及其应用
|
|
EP3128010A1
(en)
|
2007-11-28 |
2017-02-08 |
The Trustees Of The University Of Pennsylvania |
Simian subfamily e adenoviruses sadv-30 and uses thereof
|
|
HRP20170395T1
(hr)
|
2007-11-28 |
2017-05-05 |
The Trustees Of The University Of Pennsylvania |
Podporodice adenovirusa b majmuna sadv-28, 27,-29,-32,-33, i -35 i njihove primjene
|
|
US8480626B2
(en)
|
2007-11-30 |
2013-07-09 |
Medtronic, Inc. |
Infusion catheter assembly with reduced backflow
|
|
CN101977934B
(zh)
|
2008-01-18 |
2014-09-17 |
健泰科生物技术公司 |
用于靶向k63连接的多聚遍在蛋白的方法和组合物
|
|
AU2009209408B2
(en)
|
2008-01-29 |
2015-06-11 |
Beacon Therapeutics Limited |
Recombinant virus production using mammalian cells in suspension
|
|
US10131904B2
(en)
*
|
2008-02-11 |
2018-11-20 |
Rxi Pharmaceuticals Corporation |
Modified RNAi polynucleotides and uses thereof
|
|
CA2715924C
(en)
|
2008-02-19 |
2021-01-12 |
Andrew Christian BAKKER |
Optimisation of expression of parvoviral rep and cap proteins in insect cells
|
|
EP2325298B1
(en)
|
2008-03-04 |
2016-10-05 |
The Trustees Of The University Of Pennsylvania |
SIMIAN ADENOVIRUSES SAdV-36, -42.1, -42.2, AND -44 AND USES THEREOF
|
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
WO2009134681A2
(en)
|
2008-04-30 |
2009-11-05 |
The Trustees Of The University Of Pennsylvania |
Aav7 viral vectors for targeted delivery of rpe cells
|
|
CN102159713A
(zh)
|
2008-05-20 |
2011-08-17 |
Eos神经科学公司 |
用于递送光敏蛋白的载体和使用方法
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
US8951979B2
(en)
|
2008-06-13 |
2015-02-10 |
Cornell University |
Pain treatment using ERK2 inhibitors
|
|
US20110171262A1
(en)
|
2008-06-17 |
2011-07-14 |
Andrew Christian Bakker |
Parvoviral capsid with incorporated gly-ala repeat region
|
|
US8945885B2
(en)
|
2008-07-03 |
2015-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Minicircle DNA vector preparations and methods of making and using the same
|
|
JP5328244B2
(ja)
|
2008-07-07 |
2013-10-30 |
株式会社ニュージェン・ファーマ |
筋萎縮性側索硬化症治療剤
|
|
EP2318528A1
(en)
|
2008-07-24 |
2011-05-11 |
Rxi Pharmaceuticals Corporation |
Rnai constructs and uses therof
|
|
WO2010014857A2
(en)
|
2008-07-30 |
2010-02-04 |
University Of Massachusetts |
Chromosome therapy
|
|
US8796443B2
(en)
|
2008-09-22 |
2014-08-05 |
Rxi Pharmaceuticals Corporation |
Reduced size self-delivering RNAi compounds
|
|
KR20110086553A
(ko)
|
2008-09-29 |
2011-07-28 |
암스테르담 몰레큘러 테라퓨틱스 비. 브이. |
포르포빌리노겐 디아미나아제 유전자 치료
|
|
SG195557A1
(en)
|
2008-10-22 |
2013-12-30 |
Genentech Inc |
Modulation of axon degeneration
|
|
ES2552688T3
(es)
|
2008-10-31 |
2015-12-01 |
The Trustees Of The University Of Pennsylvania |
Adenovirus de simio con proteínas de la cápside hexónica de SAdV-46 y usos del mismo
|
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
US9464119B2
(en)
|
2009-03-04 |
2016-10-11 |
Deutsches Krebsforschungszentrum |
Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3
|
|
US20120093775A1
(en)
|
2009-03-27 |
2012-04-19 |
Proyecto De Biomedicina Cima, S.L. |
Methods and compositions for the treatment of cirrhosis and liver fibrosis
|
|
ES2724122T3
(es)
|
2009-04-30 |
2019-09-06 |
Univ Pennsylvania |
Composiciones para dirigir células de las vías respiratorias de conducción que comprenden construcciones de virus adenoasociado
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
EP2435575A2
(en)
|
2009-05-28 |
2012-04-04 |
Deutsches Krebsforschungszentrum |
Modified aav capsid polypeptides
|
|
CA2762203A1
(en)
|
2009-05-29 |
2010-12-02 |
Soumitra Roy |
Simian adenovirus 41 and uses thereof
|
|
HUE040636T2
(hu)
|
2009-06-16 |
2019-03-28 |
Genzyme Corp |
Javított eljárások rekombináns AAV-vektorok tisztítására
|
|
EP2451823A4
(en)
|
2009-07-06 |
2013-07-03 |
Alnylam Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR ENHANCING THE PRODUCTION OF A BIOLOGICAL PRODUCT
|
|
US20120201794A1
(en)
|
2009-07-15 |
2012-08-09 |
Calimmune Inc. |
Dual vector for inhibition of human immunodeficiency virus
|
|
EP2292781A1
(en)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
|
|
WO2011038187A1
(en)
|
2009-09-25 |
2011-03-31 |
The Trustees Of The University Of Pennsylvania |
Controlled adeno-associated virus (aav) diversification and libraries prepared therefrom
|
|
RU2606012C2
(ru)
|
2009-11-09 |
2017-01-10 |
Дженепод Терапевтикс Аб |
Новая вирусная векторная конструкция для нейронспецифического оптимизированного непрерывного синтеза dopa in vivo
|
|
WO2011062298A1
(ja)
|
2009-11-19 |
2011-05-26 |
国立大学法人岡山大学 |
遺伝子発現を上昇させるシステム及び該システムを保持したベクター
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
US9169494B2
(en)
|
2010-01-12 |
2015-10-27 |
The University Of North Carolina At Chapel Hill |
Restrictive inverted terminal repeats for viral vectors
|
|
CA2788682C
(en)
|
2010-02-05 |
2019-03-05 |
The University Of North Carolina At Chapel Hill |
Compositions and methods for enhanced parvovirus transduction
|
|
US9163261B2
(en)
|
2010-02-22 |
2015-10-20 |
Koteswara Rao KOLLIPARA |
Adeno-associated virus 2/8—micro RNA-101 therapy for liver cancer
|
|
EP2545165B1
(en)
|
2010-03-11 |
2020-07-29 |
uniQure IP B.V. |
Mutated rep encoding sequences for use in aav production
|
|
WO2011117258A2
(en)
|
2010-03-22 |
2011-09-29 |
Association Institut De Myologie |
Methods of increasing efficiency of vector penetration of target tissue
|
|
SG10201908848RA
(en)
|
2010-03-29 |
2019-10-30 |
Univ Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
|
CA2833905C
(en)
|
2010-04-23 |
2019-09-10 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
DK2826860T3
(en)
|
2010-04-23 |
2018-12-03 |
Univ Massachusetts |
CNS targeting AAV vectors and methods for their use
|
|
EP2561075B1
(en)
|
2010-04-23 |
2018-06-27 |
University of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
US9839696B2
(en)
|
2010-04-30 |
2017-12-12 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
WO2012029994A1
(en)
|
2010-09-02 |
2012-03-08 |
Kyoto University |
Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
|
|
US8808684B2
(en)
|
2010-09-10 |
2014-08-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction
|
|
EP2612909B1
(en)
|
2010-10-05 |
2015-02-25 |
Takara Bio, Inc. |
Method for producing virus vector
|
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
EP2634253B1
(en)
|
2010-10-27 |
2016-05-11 |
Jichi Medical University |
Adeno-associated virus virions for transferring genes into neural cells
|
|
WO2012064920A1
(en)
|
2010-11-11 |
2012-05-18 |
University Of Miami |
Methods, compositions, cells, and kits for treating ischemic injury
|
|
AU2011332025B2
(en)
|
2010-11-23 |
2015-06-25 |
The Trustees Of The University Of Pennsylvania |
Subfamily E simian adenoviruses A1321, A1325, A1295, A1309 and A1322 and uses thereof
|
|
ES2739804T3
(es)
|
2011-02-12 |
2020-02-04 |
Univ Iowa Res Found |
Compuestos terapéuticos
|
|
ES2724800T3
(es)
|
2011-02-17 |
2019-09-16 |
Univ Pennsylvania |
Composiciones y métodos para alterar la especificidad de tejido y mejorar la transferencia génica mediada por AAV9
|
|
GB201103062D0
(en)
|
2011-02-22 |
2011-04-06 |
Isis Innovation |
Method
|
|
EP2500434A1
(en)
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
|
EP3777843B1
(en)
|
2011-04-18 |
2023-01-04 |
National Center of Neurology and Psychiatry |
Drug delivery particle and method for producing the same
|
|
EP2699688A1
(en)
|
2011-04-20 |
2014-02-26 |
The Trustees Of The University Of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
EP3318634A1
(en)
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating diseases involving dominant-negative or gain of function mutations
|
|
DK4005603T3
(da)
|
2011-04-22 |
2024-11-25 |
Univ California |
Adeno-associerede virus-virioner med variant kapsid og fremgangsmåder til anvendelse heraf
|
|
WO2012149646A1
(en)
|
2011-05-05 |
2012-11-08 |
Sunnybrook Research Institute |
Mirna inhibitors and their uses
|
|
US9249425B2
(en)
|
2011-05-16 |
2016-02-02 |
The Trustees Of The University Of Pennslyvania |
Proviral plasmids and production of recombinant adeno-associated virus
|
|
US9598468B2
(en)
|
2011-05-18 |
2017-03-21 |
University Of Florida Research Foundation, Incorporated |
Polypeptides and vectors for targeting HER2/neu expressing cells and uses thereof
|
|
WO2012168003A1
(en)
|
2011-06-06 |
2012-12-13 |
Biocartis S.A. |
Selective lysis of cells by ionic surfactants
|
|
US20130019580A1
(en)
|
2011-07-20 |
2013-01-24 |
Anderson Noel W |
Bidirectional harvesting system
|
|
CA2842798C
(en)
|
2011-07-25 |
2021-02-23 |
Nationwide Children's Hospital, Inc. |
Recombinant virus products and methods for inhibition of expression of dux4
|
|
ES2623780T3
(es)
|
2011-07-27 |
2017-07-12 |
Genethon |
Sistemas de expresión de baculovirus mejorados
|
|
US8852911B2
(en)
|
2011-08-04 |
2014-10-07 |
The Regents Of The University Of California |
Method of producing dicer
|
|
EP3425044A1
(en)
|
2011-09-08 |
2019-01-09 |
uniQure IP B.V. |
Removal of contaminating viruses from aav preparations
|
|
WO2013036889A1
(en)
|
2011-09-09 |
2013-03-14 |
University Of Washington |
Retrograde transport peptide and use of same for delivery to central nervous system
|
|
CN104520421B
(zh)
|
2011-10-28 |
2017-05-24 |
北卡罗来纳-查佩尔山大学 |
用于生产腺伴随病毒的细胞系
|
|
HK1202434A1
(en)
|
2011-11-22 |
2015-10-02 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
|
WO2013078199A2
(en)
|
2011-11-23 |
2013-05-30 |
Children's Medical Center Corporation |
Methods for enhanced in vivo delivery of synthetic, modified rnas
|
|
WO2013103896A1
(en)
|
2012-01-06 |
2013-07-11 |
Mayo Foundation For Medical Education And Research |
Treating cardiovascular or renal diseases
|
|
JP2013143917A
(ja)
*
|
2012-01-13 |
2013-07-25 |
Mie Univ |
線維症予防又は治療剤
|
|
JP6562632B2
(ja)
|
2012-02-14 |
2019-08-21 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
心血管疾患および他の状態のためのパラクリン遺伝子の全身送達および制御された発現
|
|
WO2013123503A1
(en)
|
2012-02-17 |
2013-08-22 |
The Children's Hospital Of Philadelphia |
Aav vector compositions and methods for gene transfer to cells, organs and tissues
|
|
RU2683497C2
(ru)
|
2012-04-18 |
2019-03-28 |
Дзе Чилдрен'З Хоспитал Оф Филадельфия |
Композиция и способы высокоэффективного переноса генов с помощью вариантов капсида aav
|
|
EP2660325A3
(en)
|
2012-05-02 |
2014-02-12 |
Christian Medical College |
AAV vectors and corresponding nucleotide sequences and methods
|
|
US9163259B2
(en)
|
2012-05-04 |
2015-10-20 |
Novartis Ag |
Viral vectors for the treatment of retinal dystrophy
|
|
WO2013170078A1
(en)
|
2012-05-09 |
2013-11-14 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
|
US10294281B2
(en)
|
2012-05-15 |
2019-05-21 |
University Of Florida Research Foundation, Incorporated |
High-transduction-efficiency rAAV vectors, compositions, and methods of use
|
|
TWI702955B
(zh)
|
2012-05-15 |
2020-09-01 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒（ａａｖ）ｓｆｌｔ-１治療老年性黃斑部退化（ａｍｄ）
|
|
MX358019B
(es)
|
2012-05-18 |
2018-08-02 |
Univ Pennsylvania |
Adenovirus de simio de la subfamilia e a1302, a1320, a1331 y a1337 y sus usos.
|
|
EP2852388A4
(en)
|
2012-05-23 |
2016-01-13 |
Univ Johns Hopkins |
COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
|
|
EP2871239B1
(en)
|
2012-07-06 |
2018-08-29 |
Takara Bio Inc. |
Cell capable of producing adeno-associated virus vector
|
|
IN2015KN00074A
(enExample)
|
2012-07-06 |
2015-07-31 |
Univ Iowa Res Found |
|
|
WO2014016817A2
(en)
|
2012-07-17 |
2014-01-30 |
Universite De Geneve |
Nucleic acids for down-regulation of gene expression
|
|
EP2879719B1
(en)
|
2012-08-01 |
2018-07-04 |
Nationwide Children's Hospital |
Intrathecal delivery of recombinant adeno-associated virus 9
|
|
JP2015529685A
(ja)
|
2012-09-17 |
2015-10-08 |
ザ・リサーチ・インスティテュート・アット・ネイションワイド・チルドレンズ・ホスピタルＴｈｅ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ Ａｔｎａｔｉｏｎｗｉｄｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ |
筋萎縮性側索硬化症の処置のための組成物および方法
|
|
EP2900686B1
(en)
|
2012-09-28 |
2020-06-10 |
The University of North Carolina At Chapel Hill |
Aav vectors targeted to oligodendrocytes
|
|
US20140243783A1
(en)
|
2012-10-06 |
2014-08-28 |
Raghu Raghavan |
Method of backflow reduction during material delivery through a needle into tissue
|
|
AU2013204200B2
(en)
|
2012-10-11 |
2016-10-20 |
Brandeis University |
Treatment of amyotrophic lateral sclerosis
|
|
US9733237B2
(en)
|
2012-10-31 |
2017-08-15 |
The Trustees Of Columbia University In The City Of New York |
Methods for identifying candidates for the treatment of neurodegenerative diseases
|
|
MX363017B
(es)
|
2012-11-01 |
2019-03-04 |
Factor Bioscience Inc |
Métodos y productos para la expresión de proteínas en células.
|
|
WO2014093622A2
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
|
|
EP2940131B1
(en)
|
2012-12-25 |
2019-02-20 |
Takara Bio Inc. |
Aav variant
|
|
DK2943567T3
(en)
|
2013-01-08 |
2018-01-02 |
Genzyme Corp |
USE OF INOS INHIBITORS TO INCREASE VIRAL YIELD IN CULTURE
|
|
KR20150103280A
(ko)
|
2013-01-08 |
2015-09-09 |
베니텍 바이오파마 리미티드 |
연령-관련 황반 변성 치료
|
|
US9567376B2
(en)
|
2013-02-08 |
2017-02-14 |
The Trustees Of The University Of Pennsylvania |
Enhanced AAV-mediated gene transfer for retinal therapies
|
|
EP2970946A4
(en)
|
2013-03-13 |
2016-09-07 |
Philadelphia Children Hospital |
ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF
|
|
WO2014144844A1
(en)
|
2013-03-15 |
2014-09-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
tRNA DERIVED SMALL RNAs (tsRNAs) INVOLVED IN CELL VIABILITY
|
|
HK1220488A1
(zh)
|
2013-03-15 |
2017-05-05 |
The Children's Hospital Of Philadelphia |
含有填充者/填充物多核苷酸序列的载体及其使用方法
|
|
WO2014143932A1
(en)
|
2013-03-15 |
2014-09-18 |
The University Of North Carolina At Chapel Hill |
Synthetic adeno-associated virus inverted terminal repeats
|
|
CA3174963A1
(en)
|
2013-04-08 |
2014-10-16 |
University Of Iowa Research Foundation |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
ES2704677T3
(es)
|
2013-04-18 |
2019-03-19 |
Fond Telethon |
Suministro eficaz de genes grandes por vectores de AAV duales
|
|
EP2986632B1
(en)
|
2013-04-20 |
2018-09-05 |
Research Institute at Nationwide Children's Hospital |
Recombinant adeno-associated virus delivery of exon 2-targeted u7snrna polynucleotide constructs
|
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
|
CA2912678C
(en)
|
2013-05-15 |
2023-10-10 |
Regents Of The University Of Minnesota |
Adeno-associated virus mediated gene transfer to the central nervous system
|
|
WO2014186746A1
(en)
|
2013-05-16 |
2014-11-20 |
University Of Florida Research Foundation, Inc. |
HAIRPIN mRNA ELEMENTS AND METHODS FOR THE REGULATION OF PROTEIN TRANSLATION
|
|
CA2907799A1
(en)
|
2013-05-31 |
2014-12-04 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
WO2014201308A1
(en)
|
2013-06-12 |
2014-12-18 |
Washington University |
Endothelial-targeted adenoviral vectors, methods and uses therefor
|
|
US20160122727A1
(en)
|
2013-06-13 |
2016-05-05 |
Shire Human Genetic Therapies, Inc. |
Messenger rna based viral production
|
|
CA3209883A1
(en)
|
2013-07-22 |
2015-01-29 |
The Children's Hospital Of Philadelphia |
Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
BR112016001592A2
(pt)
|
2013-07-26 |
2017-11-28 |
Univ Iowa Res Found |
métodos e composições para o tratamento de doenças cerebrais
|
|
ITTO20130669A1
(it)
|
2013-08-05 |
2015-02-06 |
Consiglio Nazionale Ricerche |
Vettore adeno-associato ricombinante muscolo-specifico e suo impiego nel trattamento di patologie muscolari
|
|
US20160130660A1
(en)
|
2013-08-14 |
2016-05-12 |
Qiagen Mansfield, Inc. |
Compositions and methods for multimodal analysis of cmet nucleic acids
|
|
LT3702466T
(lt)
|
2013-08-27 |
2023-02-27 |
Research Institute At Nationwide Children's Hospital |
Produktai ir būdai, skirti šoninės amiotrofinės sklerozės gydymui
|
|
WO2015031686A1
(en)
|
2013-08-30 |
2015-03-05 |
Amgen Inc. |
High titer recombinant aav vector production in adherent and suspension cells
|
|
US9585971B2
(en)
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
|
WO2015048534A1
(en)
|
2013-09-26 |
2015-04-02 |
University Of Florida Research Foundation, Inc. |
Synthetic combinatorial aav capsid library for targeted gene therapy
|
|
US20160354489A1
(en)
|
2013-09-26 |
2016-12-08 |
Universitat Autònome de Barcelona |
Gene therapy compositions for use in the prevention and/or treatment of non-alcoholic fatty liver disease
|
|
ES2857751T3
(es)
|
2013-10-11 |
2021-09-29 |
Massachusetts Eye & Ear Infirmary |
Métodos para predecir secuencias de virus ancestrales y usos de los mismos
|
|
CN105745326A
(zh)
|
2013-10-24 |
2016-07-06 |
优尼科Ip有限公司 |
用于基因治疗神经疾病的aav-5假型载体
|
|
JP2016538276A
(ja)
|
2013-11-05 |
2016-12-08 |
ザ・リサーチ・インスティテュート・アット・ネイションワイド・チルドレンズ・ホスピタルＴｈｅ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ Ａｔ Ｎａｔｉｏｎｗｉｄｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ |
筋萎縮性側索硬化症の処置のためのＮＦ−κＢおよびＳＯＤ−１を阻害する組成物および方法
|
|
US20160272687A1
(en)
|
2013-11-08 |
2016-09-22 |
The Board Of Trustees Of The University Of Arkansas |
Adeno-associated virus "x" oncogene
|
|
CA2930872C
(en)
|
2013-11-26 |
2022-05-31 |
University Of Florida Research Foundation, Incorporated |
Adeno-associated virus vectors for treatment of glycogen storage disease
|
|
JP6567974B2
(ja)
|
2013-11-29 |
2019-08-28 |
タカラバイオ株式会社 |
アデノ随伴ウイルスの定量方法
|
|
SG11201604505QA
(en)
|
2013-12-03 |
2016-07-28 |
Agency Science Tech & Res |
Tailed Mirtron Effectors For RNAi-Mediated Gene Silencing
|
|
CA2932624C
(en)
|
2013-12-09 |
2023-03-28 |
Texas Heart Institute |
Treating cardiac conditions using shrna or sirna targeting salvador (sav1)
|
|
WO2015089354A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Compositions and methods of use of crispr-cas systems in nucleotide repeat disorders
|
|
GB201322798D0
(en)
|
2013-12-20 |
2014-02-05 |
Oxford Biomedica Ltd |
Production system
|
|
WO2015106273A2
(en)
|
2014-01-13 |
2015-07-16 |
Trustees Of Boston University |
Methods and assays relating to huntingtons disease and parkinson's disease
|
|
GB201401707D0
(en)
|
2014-01-31 |
2014-03-19 |
Sec Dep For Health The |
Adeno-associated viral vectors
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
WO2015124546A1
(en)
|
2014-02-19 |
2015-08-27 |
Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii- Cnic |
Aav vectors for the treatment of ischemic and non-ischemic heart disease
|
|
US10072251B2
(en)
|
2014-02-19 |
2018-09-11 |
University Of Massachusetts |
Recombinant AAVS having useful transcytosis properties
|
|
WO2015126972A1
(en)
|
2014-02-21 |
2015-08-27 |
University Of Florida Research Foundation, Inc. |
Methods and compositions for gene delivery to on bipolar cells
|
|
US10308957B2
(en)
|
2014-03-04 |
2019-06-04 |
University Of Florida Research Foundation, Inc. |
rAAV vectors and methods for transduction of photoreceptors and RPE cells
|
|
KR102572449B1
(ko)
|
2014-03-10 |
2023-08-31 |
유니큐어 아이피 비.브이. |
곤충 세포에서 생산된 더욱 향상된 aav 벡터
|
|
AU2015231294B2
(en)
|
2014-03-18 |
2020-10-29 |
University Of Massachusetts |
rAAV-based compositions and methods for treating amyotrophic lateral sclerosis
|
|
SI3757214T1
(sl)
|
2014-04-01 |
2022-08-31 |
Biogen Ma Inc. |
Sestave za moduliranje izražanja SOD-1
|
|
EP2933335A1
(en)
|
2014-04-18 |
2015-10-21 |
Genethon |
A method of treating peripheral neuropathies and motor neuron diseases
|
|
WO2015164786A1
(en)
|
2014-04-25 |
2015-10-29 |
University Of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
|
US11555059B2
(en)
|
2014-04-25 |
2023-01-17 |
The Trustees Of The University Of Pennsylvania |
LDLR variants and their use in compositions for reducing cholesterol levels
|
|
US9194250B1
(en)
|
2014-05-07 |
2015-11-24 |
General Electric Company |
Embedded wireless sensors for turbomachine component defect monitoring
|
|
MX378789B
(es)
|
2014-05-08 |
2025-03-11 |
Sangamo Biosciences Inc |
Métodos y composiciones para tratar la enfermedad de huntington.
|
|
US20170088819A1
(en)
|
2014-05-16 |
2017-03-30 |
Vrije Universiteit Brussel |
Genetic correction of myotonic dystrophy type 1
|
|
JP6663859B2
(ja)
|
2014-05-20 |
2020-03-13 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
ハンチントン病の治療化合物
|
|
US10619156B2
(en)
|
2014-05-28 |
2020-04-14 |
The Regents Of The University Of California |
Hybrid tRNA/pre-miRNA molecules and methods of use
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
US11207424B2
(en)
|
2014-06-13 |
2021-12-28 |
Mayo Foundation For Medical Education And Research |
Methods and materials for increasing viral vector infectivity
|
|
WO2015196179A1
(en)
|
2014-06-20 |
2015-12-23 |
University Of Florida Research Foundation, Inc. |
Methods of packaging multiple adeno-associated virus vectors
|
|
US10526583B2
(en)
|
2014-07-02 |
2020-01-07 |
University Of Florida Research Foundation, Incorporated |
Compositions and methods for purifying recombinant adeno-associated virus
|
|
EP3168298B1
(en)
|
2014-07-10 |
2019-04-17 |
Takara Bio Inc. |
Production method for non-enveloped virus particles
|
|
CA2955285C
(en)
|
2014-07-31 |
2023-09-26 |
Association Institut De Myologie |
Treatment of amyotrophic lateral sclerosis
|
|
WO2016019364A1
(en)
|
2014-08-01 |
2016-02-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for self-regulated inducible gene expression
|
|
EP3795580A1
(en)
|
2014-10-03 |
2021-03-24 |
University of Massachusetts |
High efficiency library-identified aav vectors
|
|
WO2016054554A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Massachusetts |
Heterologous targeting peptide grafted aavs
|
|
WO2016057975A2
(en)
|
2014-10-10 |
2016-04-14 |
Research Institute At Nationwide Children's Hospital |
Guided injections for aav gene transfer to muscle
|
|
WO2016065001A1
(en)
|
2014-10-21 |
2016-04-28 |
University Of Massachusetts |
Recombinant aav variants and uses thereof
|
|
EP3690024A1
(en)
|
2014-11-05 |
2020-08-05 |
The Research Institute at Nationwide Children's Hospital |
Methods and materials for producing recombinant viruses in eukaryotic microalgae
|
|
WO2016077607A1
(en)
|
2014-11-13 |
2016-05-19 |
The Regents Of The University Of California |
Adjustable stepped cannula
|
|
MX2017006217A
(es)
|
2014-11-14 |
2018-05-02 |
Voyager Therapeutics Inc |
Polinucleotidos moduladores.
|
|
RU2020108189A
(ru)
|
2014-11-14 |
2020-03-11 |
Вояджер Терапьютикс, Инк. |
Композиции и способы лечения бокового амиотрофического склероза (als)
|
|
EP3221456B1
(en)
|
2014-11-21 |
2021-09-22 |
University of Florida Research Foundation, Inc. |
Genome-modified recombinant adeno-associated virus vectors
|
|
BR112017010447A2
(pt)
|
2014-11-21 |
2018-05-15 |
The University Of North Carolina At Chapel Hill |
vetores de aav direcionados ao sistema nervoso central
|
|
PT3224376T
(pt)
|
2014-11-28 |
2019-10-25 |
Uniqure Ip Bv |
Impurezas de dna numa composição compreendendo um vírus parvoviral.
|
|
EP3230441A4
(en)
|
2014-12-12 |
2018-10-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
|
SMT201900347T1
(it)
|
2014-12-24 |
2019-07-11 |
Uniqure Ip Bv |
Soppressione del gene huntingtina indotta da rnai
|
|
CA2971687C
(en)
|
2014-12-30 |
2024-05-28 |
University Of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
|
US10907176B2
(en)
|
2015-01-14 |
2021-02-02 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
WO2016115503A1
(en)
|
2015-01-16 |
2016-07-21 |
Voyager Therapeutics, Inc. |
Central nervous system targeting polynucleotides
|
|
CN107427666B
(zh)
|
2015-01-30 |
2022-11-04 |
加利福尼亚大学校董 |
脊髓软膜下基因递送系统
|
|
US20180030096A1
(en)
|
2015-02-03 |
2018-02-01 |
University Of Florida Research Foundation, Inc. |
Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
|
|
NZ772772A
(en)
|
2015-02-10 |
2024-12-20 |
Genzyme Corp |
Enhanced delivery of viral particles to the striatum and cortex
|
|
SG11201706444TA
(en)
|
2015-02-10 |
2017-09-28 |
Genzyme Corp |
VARIANT RNAi
|
|
US20180245073A1
(en)
|
2015-02-23 |
2018-08-30 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
US20180094280A1
(en)
|
2015-03-20 |
2018-04-05 |
Bluebird Bio, Inc. |
Vector formulations
|
|
WO2016154344A1
(en)
|
2015-03-24 |
2016-09-29 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
WO2016161388A1
(en)
|
2015-04-03 |
2016-10-06 |
University Of Massachusetts |
Fully stabilized asymmetric sirna
|
|
CN107980062B
(zh)
|
2015-04-03 |
2022-11-25 |
马萨诸塞大学 |
用于靶向亨廷汀mRNA的寡核苷酸化合物
|
|
US10081659B2
(en)
|
2015-04-06 |
2018-09-25 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Adeno-associated vectors for enhanced transduction and reduced immunogenicity
|
|
TWI707951B
(zh)
|
2015-04-08 |
2020-10-21 |
美商健臻公司 |
過大腺相關載體之製造
|
|
EP3626274B1
(en)
|
2015-04-16 |
2025-01-22 |
Emory University |
Recombinant promoters and vectors for protein expression in liver and use thereof
|
|
EP4491733A3
(en)
|
2015-04-23 |
2025-03-26 |
University of Massachusetts |
Modulation of aav vector transgene expression
|
|
CA3021949C
(en)
|
2015-04-24 |
2023-10-17 |
University Of Massachusetts |
Modified aav constructs and uses thereof
|
|
US20160346359A1
(en)
|
2015-05-01 |
2016-12-01 |
Spark Therapeutics, Inc. |
Adeno-associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease
|
|
AU2016256894B2
(en)
|
2015-05-07 |
2020-11-26 |
Massachusetts Eye And Ear Infirmary |
Methods of delivering an agent to the eye
|
|
US9682193B2
(en)
|
2015-05-11 |
2017-06-20 |
Alcyone Lifesciences, Inc. |
Drug delivery systems and methods
|
|
CA2985786A1
(en)
|
2015-05-12 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aav isolate and fusion protein comprising nerve growth factor signal peptide and parathyroid hormone
|
|
US20170067028A1
(en)
|
2015-05-15 |
2017-03-09 |
Douglas J. Ballon |
Radiolabeling of adeno associated virus
|
|
US10729790B2
(en)
|
2015-05-26 |
2020-08-04 |
Salk Institute For Biological Studies |
Motor neuron-specific expression vectors
|
|
US11027024B2
(en)
|
2015-05-29 |
2021-06-08 |
University Of Iowa Research Foundation |
Methods of delivery of transgenes for treating brain diseases
|
|
RU2021134920A
(ru)
|
2015-05-29 |
2022-04-15 |
Дзе Трастиз Оф Дзе Юнивёрсити Оф Пенсильвания |
Композиции и способы деградации неправильно упакованных белков
|
|
WO2017004514A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Florida Research Foundation, Inc. |
Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma
|
|
US10801040B2
(en)
|
2015-07-07 |
2020-10-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the peripheral nervous system of a subject
|
|
US20170007669A1
(en)
|
2015-07-07 |
2017-01-12 |
Mayo Foundation For Medical Education And Research |
Peptide-mediated delivery of active agents across the blood-brain barrier
|
|
US20170009304A1
(en)
|
2015-07-07 |
2017-01-12 |
Splicingcodes.Com |
Method and kit for detecting fusion transcripts
|
|
WO2017015102A1
(en)
|
2015-07-17 |
2017-01-26 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for achieving high levels of transduction in human liver cells
|
|
US20180214576A1
(en)
|
2015-07-28 |
2018-08-02 |
University Of Massachusetts |
Transgenic expression of dnasei in vivo delivered by an adeno-associated virus vector
|
|
CA2994160C
(en)
|
2015-07-30 |
2021-08-10 |
Massachusetts Eye And Ear Infirmary |
Ancestral virus sequences and uses thereof
|
|
WO2017024111A1
(en)
|
2015-08-04 |
2017-02-09 |
The University Of Chicago |
Inhibitors of cacna1a/alpha1a subunit internal ribosomal entry site (ires) and methods of treating spinocerebellar ataxia type 6
|
|
US10047377B2
(en)
|
2015-09-22 |
2018-08-14 |
Loyola University Of Chicago |
Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor
|
|
JP7064214B2
(ja)
|
2015-09-28 |
2022-05-10 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
抗体回避性ウイルスベクターのための方法および組成物
|
|
EP3359666B1
(en)
|
2015-10-09 |
2025-02-19 |
Genzyme Corporation |
Early post-transfection isolation of cells (epic) for biologics production
|
|
AU2016335572B2
(en)
|
2015-10-09 |
2022-12-08 |
The Children's Hospital Of Philadelphia |
Compositions and methods for treating Huntington's disease and related disorders
|
|
US10123969B2
(en)
|
2015-10-15 |
2018-11-13 |
Wisconsin Alumni Research Foundation |
Osmotic enhancement of drug/therapeutic delivery to the brain following infusion or injection into the cerebrospinal fluid
|
|
US11426469B2
(en)
|
2015-10-22 |
2022-08-30 |
University Of Massachusetts |
Prostate-targeting adeno-associated virus serotype vectors
|
|
WO2017070525A1
(en)
|
2015-10-22 |
2017-04-27 |
University Of Massachusetts |
Methods and compositions for treating metabolic imbalance in neurodegenerative disease
|
|
US12188037B2
(en)
|
2015-10-22 |
2025-01-07 |
University Of Florida Research Foundation, Incorporated |
Synthetic combinatorial AAV3 capsid library
|
|
CN108601771B
(zh)
|
2015-10-23 |
2023-02-21 |
衣阿华大学研究基金会 |
使用基因疗法以推迟疾病发生和发展同时提供认知保护来治疗神经变性疾病的方法
|
|
WO2017075335A1
(en)
|
2015-10-28 |
2017-05-04 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
CN108602884B
(zh)
|
2015-11-08 |
2024-06-25 |
豪夫迈·罗氏有限公司 |
筛选多特异性抗体的方法
|
|
WO2017083423A1
(en)
|
2015-11-10 |
2017-05-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for modulating aav infection
|
|
KR20180091863A
(ko)
|
2015-12-01 |
2018-08-16 |
스파크 테라퓨틱스, 인코포레이티드 |
임상적 사용에 적합한 무혈청 현탁 세포 배양 시스템에서 재조합 아데노-관련 바이러스(aav) 벡터를 생성하기 위한 확장가능한 방법
|
|
US20170151416A1
(en)
|
2015-12-01 |
2017-06-01 |
Invivo Therapeutics Corporation |
Methods and Systems for Delivery of a Trail of a Therapeutic Substance into an Anatomical Space
|
|
US10406244B2
(en)
|
2015-12-02 |
2019-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
AAV vectors with expanded packaging capacity
|
|
EP3384034B1
(en)
|
2015-12-02 |
2020-07-08 |
The Board of Trustees of the Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
|
|
CA3004971A1
(en)
|
2015-12-03 |
2017-06-08 |
Universite D'evry Val D'essonne |
Compositions and methods for improving viral vector efficiency
|
|
EP3387118B1
(en)
|
2015-12-11 |
2022-04-06 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aavrh10
|
|
WO2017100676A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
|
US11015173B2
(en)
|
2015-12-11 |
2021-05-25 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV1
|
|
US11098286B2
(en)
|
2015-12-11 |
2021-08-24 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV9
|
|
DK3387137T3
(da)
|
2015-12-11 |
2021-05-03 |
California Inst Of Techn |
Målretningspeptider til styring af adeno-associerede virusser (aav`er)
|
|
CN108602859B
(zh)
|
2015-12-14 |
2023-05-26 |
北卡罗来纳大学教堂山分校 |
增强细小病毒载体递送的修饰衣壳蛋白
|
|
WO2017112948A1
(en)
|
2015-12-24 |
2017-06-29 |
University Of Florida Research Foundation, Inc. |
Improved aav production using suspension adapted cells
|
|
EP3403675B1
(en)
|
2016-01-15 |
2021-04-21 |
Jichi Medical University |
Adeno-associated virus virion for use in treatment of epilepsy
|
|
EP3411059A4
(en)
|
2016-02-02 |
2019-10-16 |
University Of Massachusetts |
METHOD FOR INCREASING THE EFFECTIVENESS OF THE SYSTEMIC DELIVERY OF AVV GENES TO THE CENTRAL NERVOUS SYSTEM
|
|
LT3411484T
(lt)
|
2016-02-05 |
2023-11-27 |
Emory University |
Viengrandžio arba sau pačiam komplementaraus adeno-asocijuoto viruso 9 injekcija į smegenų skystį
|
|
WO2017139381A1
(en)
|
2016-02-08 |
2017-08-17 |
University Of Iowa Research Foundation |
Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
|
|
WO2017143100A1
(en)
|
2016-02-16 |
2017-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
|
|
WO2017147477A1
(en)
|
2016-02-26 |
2017-08-31 |
University Of Florida Research Foundation, Inc. |
Aav heparin mutants that display significantly improved eye and brain transduction
|
|
EP3423110B1
(en)
|
2016-03-03 |
2021-08-11 |
University of Massachusetts |
Closed-ended linear duplex dna for non-viral gene transfer
|
|
IL322737A
(en)
|
2016-03-07 |
2025-10-01 |
Univ Iowa Res Found |
AAV-mediated expression using a synthetic promoter and enhancer
|
|
WO2017165859A1
(en)
|
2016-03-24 |
2017-09-28 |
Research Institute At Nationwide Children's Hospital |
Modified viral capsid proteins
|
|
WO2017172733A1
(en)
|
2016-03-28 |
2017-10-05 |
The Regents Of The University Of California |
Anti-ryk antibodies and methods of using the same
|
|
ES2938833T3
(es)
|
2016-03-28 |
2023-04-17 |
Ultragenyx Pharmaceutical Inc |
Métodos de inactivación térmica de adenovirus
|
|
SG11201808398PA
(en)
|
2016-03-30 |
2018-10-30 |
Spark Therapeutics Inc |
Cell line for recombinant protein and/or viral vector production
|
|
PH12018502104B1
(en)
|
2016-03-31 |
2024-03-27 |
Spark Therapeutics Inc |
Column-based fully scalable raav manufacturing process
|
|
AU2017248656B2
(en)
|
2016-04-15 |
2023-07-27 |
The Trustees Of The University Of Pennsylvania |
Novel AAV8 mutant capsids and compositions containing same
|
|
JP6975980B2
(ja)
|
2016-04-16 |
2021-12-01 |
ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド |
バキュロウイルス系で産生される組換えアデノ随伴ウイルスの生物学的力価を増強する方法
|
|
AU2017254652B2
(en)
|
2016-04-21 |
2022-12-01 |
Virovek, Inc. |
AAV production in insect cells, methods and compositions therefor
|
|
EP3235516B1
(en)
|
2016-04-22 |
2019-06-26 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin |
Regulatable adeno-associated virus (aav) vector
|
|
WO2017190031A1
(en)
|
2016-04-28 |
2017-11-02 |
Indiana University Research And Technology Corporation |
Methods and compositions for resolving components of a virus preparation
|
|
EP3448875A4
(en)
|
2016-04-29 |
2020-04-08 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
AU2017261249B2
(en)
|
2016-05-03 |
2021-05-06 |
Children's Medical Research Institute |
Adeno-associated virus polynucleotides, polypeptides and virions
|
|
US11866462B2
(en)
|
2016-05-04 |
2024-01-09 |
Oregon Health & Science University |
Recombinant adeno-associated viral vectors
|
|
AU2017267665C1
(en)
|
2016-05-18 |
2023-10-05 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
BR112018073472A2
(pt)
|
2016-05-18 |
2019-08-27 |
Voyager Therapeutics, Inc. |
composições e métodos de tratamento da doença de huntington
|
|
CA3061652A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
CN110914427B
(zh)
|
2017-05-05 |
2024-08-09 |
沃雅戈治疗公司 |
调节性多核苷酸
|
|
WO2018220211A1
(en)
|
2017-06-02 |
2018-12-06 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Viral vector combining gene therapy and genome editing approaches for gene therapy of genetic disorders
|
|
WO2019028306A2
(en)
|
2017-08-03 |
2019-02-07 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR ADMINISTRATION OF ADENO-ASSOCIATED VIRUSES
|
|
CN111479924B
(zh)
|
2017-10-16 |
2024-06-14 |
沃雅戈治疗公司 |
肌萎缩性侧索硬化症(als)的治疗
|
|
US20200237799A1
(en)
|
2017-10-16 |
2020-07-30 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
|
TW202015742A
(zh)
|
2018-05-15 |
2020-05-01 |
美商航海家醫療公司 |
投遞腺相關病毒（ａａｖ）之組成物和方法
|
|
US20210361318A1
(en)
|
2018-07-02 |
2021-11-25 |
Voyager Therapeutics, Inc. |
Cannula system and use thereof
|
|
US20210254103A1
(en)
|
2018-07-02 |
2021-08-19 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
WO2020223296A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
WO2023092002A2
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis and disorders associatedwith the spinal cord
|